Verve Therapeutics
VERV
#7075
Rank
C$0.54 B
Marketcap
$6.42
Share price
1.10%
Change (1 day)
-62.14%
Change (1 year)

EPS for Verve Therapeutics (VERV)

EPS in 2023 (TTM): -$4.28

According to Verve Therapeutics's latest financial reports the company's current EPS (TTM) is -$4.43. In 2022 the company made an earnings per share (EPS) of -$4.08 a decrease over its 2021 EPS that were of -$3.53.

EPS history for Verve Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.284.94%
2022-$4.0815.54%
2021-$3.5361.32%
2020-$2.19